Log in
Enquire now

List of MyMD Pharmaceuticals patents

List of MyMD Pharmaceuticals patents
List of DCA Design International Ltd patents
List of Trico Products patents
List of Centers for Disease Control and Prevention patents
List of funding rounds for DFine
List of companies in GT Healthcare Capital Partners's investment portfolio
Patents where
Current Assignee
Name
is
MyMD PharmaceuticalsMyMD Pharmaceuticals
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10918633 Method of treating coronavirus

Patent 10918633 was granted and assigned to MyMD Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office.

MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10918633
February 16, 2021
‌
US Patent 9884055 Method of treating substance addictions

Patent 9884055 was granted and assigned to MyMD Pharmaceuticals on February, 2018 by the United States Patent and Trademark Office.

MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9884055
February 6, 2018
‌
US Patent 10517856 Methods of altering programmed cell death and extending cell life

Patent 10517856 was granted and assigned to MyMD Pharmaceuticals on December, 2019 by the United States Patent and Trademark Office.

MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10517856
December 31, 2019
‌
US Patent 10471052 Method of treating addictions to opioids

Patent 10471052 was granted and assigned to MyMD Pharmaceuticals on November, 2019 by the United States Patent and Trademark Office.

MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10471052
November 12, 2019
‌
US Patent 10588899 Methods of treating diabetes

Patent 10588899 was granted and assigned to MyMD Pharmaceuticals on March, 2020 by the United States Patent and Trademark Office.

MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10588899
March 17, 2020
‌
US Patent 10786493 Method of treating viral infections

Patent 10786493 was granted and assigned to MyMD Pharmaceuticals on September, 2020 by the United States Patent and Trademark Office.

MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10786493
September 29, 2020
‌
US Patent 10806728 Pharmaceutical salts of isomyosmine and pharmaceutical compositions containing same

Patent 10806728 was granted and assigned to MyMD Pharmaceuticals on October, 2020 by the United States Patent and Trademark Office.

MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10806728
October 20, 2020
‌
US Patent 10835523 Method of regulating tumor necrosis factor-alpha (TNF-α) for treating cancers, autoimmune disorders, and other disorders associated with chronic inflammation

Patent 10835523 was granted and assigned to MyMD Pharmaceuticals on November, 2020 by the United States Patent and Trademark Office.

MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10835523
November 17, 2020
‌
US Patent 11629355 Synthetic cannabinoid compounds for treatment of epilepsy, substance addiction and Alzheimer's disease

Patent 11629355 was granted and assigned to MyMD Pharmaceuticals on April, 2023 by the United States Patent and Trademark Office.

MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11629355
April 18, 2023
‌
US Patent 10722506 Method of treating multiple sclerosis

Patent 10722506 was granted and assigned to MyMD Pharmaceuticals on July, 2020 by the United States Patent and Trademark Office.

MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10722506
July 28, 2020
‌
US Patent 10213438 Alkaloid compounds for treating depression, substance addictions, and indications associated with chronic inflammation

Patent 10213438 was granted and assigned to MyMD Pharmaceuticals on February, 2019 by the United States Patent and Trademark Office.

MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10213438
February 26, 2019
‌
US Patent 11938126 Method of treating diseases of the visual system

Patent 11938126 was granted and assigned to MyMD Pharmaceuticals on March, 2024 by the United States Patent and Trademark Office.

MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
MyMD Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11938126
March 26, 2024
12 results
0 selected
12 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us